AMY FUNARI: Open Payments
NPI 1891126058 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 8 payments from 6 companies in 2025. Trend: 2023 $383 · 2024 $486 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 2 | $53 |
| SCPHARMACEUTICALS INC. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $17 |
Products named: UPTRAVI, FUROSCIX, JARDIANCE, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, VERQUVO, LifeVest.
Industry payments across CA — which companies pay providers there.
